Describe how genetic and molecular factors contribute to Alzheimer’s disease risk and resilience, and how these mechanisms differ from traditional disease risk pathways.
Explain how large-scale harmonization of genomics, biomarkers, neuroimaging, and cognition enables precision medicine and the identification of novel therapeutic targets.
Identify emerging genetic, vascular, immune, and sex-specific pathways associated with resilience to Alzheimer’s disease.